
Institute of Neuromodulation
Promote research and innovation to advance neuromodulation
About ION
ION, the Institute of Neuromodulation, was established to foster cross-disciplinary collaboration among eminent thought leaders to promote research and innovation in the field of neuromodulation.
Neuromodulation combines therapeutic technologies to modulate the nervous system’s function, including the brain, spinal cord, peripheral nerves, and organs of special sense (vision, hearing, touch, smell, and taste).
ION is concerned with all aspects of the advancement of neuromodulation therapy, including matters related to science, technology, and policy matters that impact the people’s health in this nation and the world.

Mission
ION shall promote research and innovation to advance the field of neuromodulation to improve health and quality of life for patients.
Vision
- Promote patient safety and appropriate access to neuromodulation therapies using the best evidence.
- Raise awareness of the benefits, cost-effectiveness and value of neuromodulation therapies.
- Improve the understanding of the mechanisms, expand the indications, and enhance the evidence base for neuromodulation therapies by supporting clinical, basic science and translational research.
Executive Committee
Albert Leung, MD
- Professor of Anesthesiology and Pain Medicine
- University of California San Diego
- San Diego, CA
Dario J. Englot, MD, PhD
- Director of Functional Neurosurgery
- Vanderbilt University Medical Center
- Nashville, TN
Julie Pilitsis, MD, PhD
Peter Staats, MD, MBA
- Chair
- National Spine and Pain Centers
- Atlantic Beach, FL
Pierre D’Haese, PhD
- Founder and CEO
- Neurotargeting, LLC
- Nashville, TN
Clinical Advisors
Brian Kopell, MD
- Professor of Neurosurgery, Neurology, Psychiatry and Neuroscience
- Mount Sinai Health System
- New York, NY
Gregory Fiore, MD
- Founder
- Fiore Healthcare Advisors, Inc.
- Boston, MA
Steven Falowski, MD
- Director of Functional Neurosurgery
- St. Luke’s University Health Network
- Bethlehem, PA
Vibhor Krishna, MBBS
- Assistant Professor, Dept. of Neurological Surgery
- Ohio State University Wexner Medical Center
- Columbus, OH
Salim Hayek, MD, PhD
Chief of the Division of Pain Medicine;
University Hospitals, Cleveland Medical Center,
Cleveland, OH
Non-Clinical Advisors
Joseph Pancrazio, PhD
- Professor
- Vice President for Research
- University of Texas at Dallas
- Dallas, TX
Robert Foreman, PhD
- George Lynn Cross Professor Emeritus
- University of Oklahoma Health Sciences Center
- Oklahoma City, OK
Please follow the links below to learn more about the Institute of Neuromodulation’s committees and projects.
Please see below for the Institute of Neuromodulation’s publications.
- North, R.B., Konrad, P.E., Judy, J.W., Ries, A.J., Steverson, R. Examining the Need to Standardize Implanted Stimulator Connectors: NANS Survey Results – Neuromodulation 2020 Aug 11. doi: 10.1111/ner.13231
- Duarte, R.V. et al., 2020: Randomized Placebo‐/Sham‐Controlled Trials of Spinal Cord Stimulation: A Systematic Review and Methodological Appraisal. Neuromodulation. doi:10.1111/ner.13018
- Duarte, R.V. et al., 2020: Systematic Review and Meta-Analysis of Placebo/Sham Controlled Randomised Trials of Spinal Cord Stimulation for Neuropathic Pain. Pain 161:24-30
- McNicol E. et al., 2020: Systematic Review of Research Methods and Reporting Quality of Randomized Clinical Trials of Spinal Cord Stimulation for Pain. Journal of Pain: 2020 Jun 20:S1526-5900(20)30040-7. doi: 10.1016/j.jpain.2020.05.001.
- Katz N. et al., 2021: Research Design Considerations for Randomized Controlled Trials of Spinal Cord Stimulation for Pain: IMMPACT/ION/INS Recommendations. Pain: January 18, 2021, doi: 10.1097/j.pain.0000000000002204